YinWei Ho

1.6k total citations
14 papers, 1.1k citations indexed

About

YinWei Ho is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, YinWei Ho has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in YinWei Ho's work include Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). YinWei Ho is often cited by papers focused on Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). YinWei Ho collaborates with scholars based in United States, United Kingdom and Singapore. YinWei Ho's co-authors include Ravi Bhatia, Ling Li, Tessa L. Holyoake, Bin Zhang, Tinisha McDonald, Zhiqiang Wang, Liang Li, Lisheng Wang, Wenyong Chen and Su Chu and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Cell.

In The Last Decade

YinWei Ho

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
YinWei Ho United States 10 608 530 263 262 168 14 1.1k
Yuri Kamitsuji Japan 16 369 0.6× 449 0.8× 294 1.1× 223 0.9× 49 0.3× 32 929
Lorena Lôbo de Figueiredo-Pontes Brazil 15 664 1.1× 228 0.4× 129 0.5× 258 1.0× 300 1.8× 50 1.1k
A M Martelli Italy 10 580 1.0× 198 0.4× 91 0.3× 191 0.7× 91 0.5× 17 785
Ya‐Huei Kuo United States 15 579 1.0× 357 0.7× 94 0.4× 235 0.9× 114 0.7× 44 930
Jennifer E. Amengual United States 15 574 0.9× 76 0.1× 137 0.5× 408 1.6× 36 0.2× 87 1.1k
Tri K. Nguyen United States 8 274 0.5× 136 0.3× 83 0.3× 99 0.4× 43 0.3× 10 460
Nicolas Chatain Germany 16 373 0.6× 253 0.5× 270 1.0× 137 0.5× 43 0.3× 45 735
Shuhei Koide Japan 17 649 1.1× 276 0.5× 93 0.4× 171 0.7× 141 0.8× 48 932
Mike Zhong China 6 357 0.6× 516 1.0× 56 0.2× 566 2.2× 28 0.2× 21 881

Countries citing papers authored by YinWei Ho

Since Specialization
Citations

This map shows the geographic impact of YinWei Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by YinWei Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites YinWei Ho more than expected).

Fields of papers citing papers by YinWei Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by YinWei Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by YinWei Ho. The network helps show where YinWei Ho may publish in the future.

Co-authorship network of co-authors of YinWei Ho

This figure shows the co-authorship network connecting the top 25 collaborators of YinWei Ho. A scholar is included among the top collaborators of YinWei Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with YinWei Ho. YinWei Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Irvine, David, Bin Zhang, Ross Kinstrie, et al.. (2016). Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Scientific Reports. 6(1). 25476–25476. 58 indexed citations
2.
Agarwal, Puneet, Bin Zhang, YinWei Ho, et al.. (2016). Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI. Blood. 129(8). 1008–1020. 55 indexed citations
3.
Zhang, Bin, Ling Li, YinWei Ho, et al.. (2016). Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells. Journal of Clinical Investigation. 126(3). 975–991. 43 indexed citations
4.
Zhang, Bin, et al.. (2015). Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development. Blood. 125(17). 2678–2688. 101 indexed citations
5.
Qi, Jing, Sandeep Singh, Qi Cai, et al.. (2015). HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation. Cell stem cell. 17(5). 597–610. 85 indexed citations
6.
Agarwal, Puneet, Bin Zhang, YinWei Ho, et al.. (2015). Inhibition of CML Stem Cell Renewal By the Porcupine Inhibitor WNT974. Blood. 126(23). 54–54. 3 indexed citations
7.
Li, Liang, YinWei Ho, Allen Lin, et al.. (2014). Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells. Blood. 123(18). 2826–2837. 84 indexed citations
8.
Wang, Lisheng, Ling Li, Liang Li, et al.. (2014). MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors. Blood. 125(8). 1302–1313. 128 indexed citations
9.
Agarwal, Puneet, Bin Zhang, YinWei Ho, et al.. (2014). Inhibition of CML Stem Cell Growth By Targeting WNT Signaling Using a Porcupine Inhibitor. Blood. 124(21). 3130–3130. 2 indexed citations
10.
11.
Li, Ling, Lisheng Wang, Liang Li, et al.. (2012). Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib. Cancer Cell. 21(2). 266–281. 327 indexed citations
12.
Li, Ling, Tinisha McDonald, Liang Li, et al.. (2012). FLT3-ITD+ AML Stem/Progenitor Cells Demonstrate Increased SIRT1 Expression and Enhanced Sensitivity to SIRT1 Inhibition. Blood. 120(21). 1368–1368. 1 indexed citations
13.
Zhang, Bin, Adam C. Strauss, Su Chu, et al.. (2010). Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate. Cancer Cell. 17(5). 427–442. 199 indexed citations
14.
Ong, Danny, YinWei Ho, Christina Rudduck, et al.. (2009). LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. Oncogene. 28(47). 4189–4200. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026